See every side of every news story
Published loading...Updated

Ozempic Is Changing More Than Waistlines as Scientists Wise Up to Concerning Side Effects

UNITED KINGDOM, JUL 09 – Rapid weight loss from GLP-1 drugs like Ozempic causes skin sagging and sensitivity, affecting an estimated 500,000 UK users, with some experiencing pronounced facial aging.

  • A major study published in January 2025 analyzed health benefits and risks of GLP-1RA drugs like Ozempic and Wegovy for over 215,000 patients in the US and UK.
  • These drugs, initially for diabetes and approved for weight loss in 2021, have rapidly grown in popularity with over 2 million US users and 13% prescription growth recently.
  • The study found broad health benefits including reduced risks for 42 conditions such as heart attacks and Alzheimer’s, but also identified increased risks of 19 mostly rare and serious side effects like pancreatitis and NAION.
  • Experts including Skibicka and Al-Aly emphasized that benefits outweigh risks if drugs are taken as prescribed, though they urge monitoring, more research especially on women, and safer prescribing guidelines.
  • The findings suggest GLP-1RA drugs will remain widely used but require caution and further study to mitigate rare severe effects and address emerging concerns like skin aging linked to rapid weight loss.
Insights by Ground AI
Does this summary seem wrong?

12 Articles

All
Left
1
Center
4
Right
2
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

IBTimes UK broke the news in United Kingdom on Wednesday, July 9, 2025.
Sources are mostly out of (0)